The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(1-ethoxycarbonyl piperazin-4-yl)acetamide dihydrochloride ID: ALA4476066
PubChem CID: 155537748
Max Phase: Preclinical
Molecular Formula: C24H38Cl2N4O4
Molecular Weight: 444.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)N1CCN(CC(=O)Nc2ccc(OC3CCN(C4CCC4)CC3)cc2)CC1.Cl.Cl
Standard InChI: InChI=1S/C24H36N4O4.2ClH/c1-2-31-24(30)28-16-14-26(15-17-28)18-23(29)25-19-6-8-21(9-7-19)32-22-10-12-27(13-11-22)20-4-3-5-20;;/h6-9,20,22H,2-5,10-18H2,1H3,(H,25,29);2*1H
Standard InChI Key: SPHXQTQHNWMMOJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 35 0 0 0 0 0 0 0 0999 V2000
36.0643 -24.1018 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.9691 -21.5580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9679 -22.3855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6827 -22.7983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3991 -22.3850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3963 -21.5544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6809 -21.1453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2545 -21.1457 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5402 -21.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8214 -21.1429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1092 -21.5521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1051 -22.3774 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8196 -22.7919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5380 -22.3811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1143 -22.7964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8281 -22.3827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5432 -22.7941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8268 -21.5577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.2570 -22.3805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.3900 -22.7852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5938 -22.5689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3775 -23.3650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1736 -23.5814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9688 -22.7963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6804 -22.3862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6834 -21.5608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9685 -21.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2505 -21.5591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3988 -21.1499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1123 -21.5640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.4006 -20.3249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.8277 -21.1530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5413 -21.5671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5857 -24.1607 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
2 8 1 0
8 9 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
5 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 20 1 0
12 20 1 0
19 24 1 0
19 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
26 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 444.58Molecular Weight (Monoisotopic): 444.2737AlogP: 2.79#Rotatable Bonds: 7Polar Surface Area: 74.35Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.97CX Basic pKa: 9.11CX LogP: 1.93CX LogD: 0.22Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.70Np Likeness Score: -1.45
References 1. Nirogi R, Shinde A, Mohammed AR, Badange RK, Reballi V, Bandyala TR, Saraf SK, Bojja K, Manchineella S, Achanta PK, Kandukuri KK, Subramanian R, Benade V, Palacharla RC, Jayarajan P, Pandey S, Jasti V.. (2019) Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity., 62 (3): [PMID:30629436 ] [10.1021/acs.jmedchem.8b01280 ]